Welcome to our dedicated page for Restart Life news (Ticker: NMLSF), a resource for investors and traders seeking the latest updates and insights on Restart Life stock.
Restart Life Sciences Corp. (OTC Pink: NMLSF) is a Canadian-based life sciences company listed on the CSE under the symbol HEAL. This news page aggregates company announcements and developments related to its health and wellness product portfolio, financing activities, and strategic transactions.
Recent company news highlights the introduction and development of functional wellness brands such as BrainQ™ and BrainBalls™, which are described as supporting cognitive health, brain wellness, and overall well-being. Updates also cover the company’s food technology and research initiatives, which are intended to support ingredient assessment, formulation performance, and future product development across its brands.
Investors and observers can follow news about Restart Life Sciences’ capital-raising efforts, including non-brokered private placements, warrant exercises, and loan financings. The company reports that these financings are intended to fund health food trials, research initiatives, potential acquisitions, and general working capital.
A key topic in recent announcements is a binding letter of intent to acquire Holy Crap Foods Inc. from Happy Belly Food Group Inc., subject to customary conditions and regulatory approvals. News items describe how this proposed acquisition would add the Holy Crap brand portfolio and a co-packer production facility in British Columbia, supporting vertical integration and providing a platform for Restart Life Sciences’ own product lines.
By reviewing this news feed, readers can track how Restart Life Sciences communicates its progress on product launches, research programs, proposed acquisitions, and financing milestones within the health and wellness and functional food sectors.
Restart Life Sciences (OTC Pink: NMLSF) highlighted its Holy Crap certified manufacturing platform on March 11, 2026, citing Organic, Kosher, Non-GMO, SQF, Safe Food for Canadians licence and FDA registration. The facility supports margin expansion, reduced co-packing reliance, broader retail and export distribution, and a University of Manitoba collaboration for ingredient validation. The company also granted 1,000,000 RSUs to consultants under its existing plan.
Restart Life Sciences (OTC Pink: NMLSF) announced a research collaboration with the University of Manitoba Richardson Centre for Food Technology and Research on March 3, 2026, following its acquisition of Holy Crap Foods.
The program will support formulation validation, ingredient functionality, bioavailability assessment, stability testing, and technical recommendations across BrainQ™, BrainBalls™, Holy Crap™ and future functional foods.
Restart Life Sciences (OTC: NMLSF) closed its acquisition of Holy Crap Foods effective February 27, 2026, adding in excess of $1 million in annualized revenue and making Restart Life a revenue-producing company.
The deal transfers Holy Crap's full brand portfolio, IP, customer and supplier contracts, inventory, and a turnkey manufacturing facility in Gibsons, BC, enabling immediate operational continuity and reduced near-term capital expenditure while supporting the company's growth plans in health and wellness.
Restart Life Sciences (OTC Pink: NMLSF) entered a Definitive Agreement dated February 12, 2026 to acquire 100% of Holy Crap Foods for $1,000,000 cash, subject to customary working capital adjustments.
Closing is anticipated within ten business days pending customary conditions; Holy Crap will operate as a wholly owned subsidiary and includes a British Columbia manufacturing facility.
Restart Life Sciences (OTC Pink: NMLSF) received aggregate gross proceeds of approximately CAD$590,000 on December 22, 2025 from warrant exercises and a corporate loan.
Holders exercised 4,103,023 warrants for about CAD$340,000, including the CEO's exercise of 1,303,023 warrants for roughly CAD$130,000. The company also closed a CAD$250,000 arm's-length loan at 12% annual interest, payable monthly, with a 12-month term and renewal option.
Net proceeds are intended to advance a binding LOI dated December 22, 2025 to acquire 100% of Holy Crap Foods from Happy Belly Food Group (CSE: HBFG), support planned Food Studies, and for general working capital; closing remains subject to due diligence, definitive agreements and regulatory approvals including CSE approval.
Restart Life Sciences (OTC Pink: NMLSF) signed a binding LOI dated December 21, 2025 to acquire 100% of Holy Crap Foods from Happy Belly Food Group for a CAD$1,000,000 purchase price subject to working capital adjustments.
Restart paid a CAD$100,000 deposit (10% of the price). The transaction includes the Holy Crap brand portfolio and a British Columbia co-packer facility to produce Restart's Brain Balls and other lines. The parties expect closing in early 2026, subject to Canadian Securities Exchange approval, with a business acquisition report due within 75 days of closing. Post-closing payment adjustments may be made within 12 months and will be secured against Holy Crap assets.
Restart Life Sciences (OTC: NMLSF) closed an over-subscribed second tranche of a non-brokered private placement on December 18, 2025, raising gross proceeds of CDN$630,000 in the tranche and CDN$1,130,000 in total across two tranches.
The company issued 6,300,000 units at CDN$0.10 per unit; each unit includes one common share and one transferable warrant exercisable for one year at CDN$0.10. The company also issued 132,000 non-transferable finder warrants exercisable for one year at CDN$0.10. Proceeds are earmarked for health food trials, potential acquisitions, and general working capital. Securities are subject to a four-month-and-one-day hold expiring April 18, 2026.
Restart Life Sciences (OTC Pink: NMLSF) announced on December 17, 2025 that it will allocate capital to support newly planned food-related research initiatives aimed at its consumer health portfolio.
The company said it will narrow preferred research partners, pursue studies on ingredient quality, formulation performance, stability, sensory attributes and preliminary bioavailability, and expects findings to inform product refinement for brands such as BrainQ and BrainBalls. Additional updates will follow as research parameters and partnerships are defined.
Restart Life Sciences (OTC Pink: NMLSF) closed the first tranche of a non-brokered private placement on December 5, 2025, raising CDN$500,000 by issuing 5,000,000 units at CDN$0.10 per unit. Each unit includes one common share and one one-year warrant exercisable at CAD$0.10. The company paid CAD$16,800 in cash finder's fees and issued 60,000 non-transferable finder warrants exercisable at CAD$0.10 for one year. Proceeds are intended for health food trials, potential acquisitions, and general working capital. All securities are subject to a hold period ending April 6, 2026.